QIAGEN Gains FDA Clearance for Bloodstream Infection Testing
Germantown, Maryland, and Venlo, Netherlands, August, 10, 2026 QIAGEN has received U.S. Food and Drug Administration (FDA) clearance for...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Germantown, Maryland, and Venlo, Netherlands, August, 10, 2026 QIAGEN has received U.S. Food and Drug Administration (FDA) clearance for...
Salt Lake City, Utah, August 6, 2026 BlueWind Medical, Ltd. has received U.S. Food and Drug Administration (FDA) 510(k)...
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 5, 2026 BriaCell Therapeutics Corp. has received U.S. Food and Drug Administration (FDA)...
Chicago, Illinois – August 3, 2026 Meitheal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Cambridge, Massachusetts, August 3, 2026 Akebia Therapeutics, Inc. announced the initiation of an open-label Phase 2 basket trial of...
New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...
VANCOUVER, BC, July 30, 2026 Total Flow Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
NORWOOD, Mass., July 28, 2026 Corbus Pharmaceuticals Holdings, Inc. has received U.S. Food and Drug Administration (FDA) clearance to...
